Replimune Group, Inc. - Common Stock (NQ:REPL)

REPL UPCOMING DEADLINE: Levi & Korsinsky Alerts Replimune Group, Inc. Stockholders of Securities Class Action - Contact the Firm

October 02, 2026

From Levi & Korsinsky, LLP

Via ACCESS Newswire

Performance

52-Week Range 27.6% below 52-week high

11.83

1.5052W Low 16.3352W High

1 Week 4.4% below 1-week high

10.671W Low 12.371W High

Replimune Group, Inc. - Common Stock (REPL) traded between $1.50 and $16.33 over the past 52 weeks and last traded at $11.83, 27.6% below its 52-week high. Over the past week it ranged between $10.67 and $12.37.

Past 12 Months

+3.9%

-8.1%

+7.5%

+536.0%

+32.9%

+32.3%

1W +$0.44

1M -$1.04

3M +$0.83

6M +$9.97

YTD +$2.93

1Y +$2.88

REPL was +32.3% over the past year, +536.0% over six months, +32.9% year to date, +3.9% in the last week.

12 Months vs Market

REPL

+32.3%

DIA

+12.2%

SPY

+14.8%

QQQ

+18.3%

IWM

+11.5%

Over the past 12 months REPL returned +32.3% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.8%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +11.5%.

Volume & Liquidity 0.14× 3-mo avg

Today 538,453 3-mo avg 3.8M

1.6M

2.0M

3.8M

4.9M

YTD

4.3M

REPL most recently traded 538,453 shares against a 3-month average daily volume of 3.8M.

More News

Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma

October 01, 2026

From Replimune, Inc.

REPLIMUNE CLASS ACTION DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urgently Reminds Replimune Group Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 5th

September 29, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

September 29, 2026

Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1

September 28, 2026

Via Newsfile

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

September 22, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

September 15, 2026

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Replimune Group Inc. and Encourages Investors to Contact the Firm

September 11, 2026

REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky

September 11, 2026

From Levi & Korsinsky, LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

September 08, 2026

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law

September 08, 2026

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law

September 04, 2026

Replimune to Present at the Cantor Global Healthcare Conference 2026

September 03, 2026

From Replimune, Inc.

Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc.

September 02, 2026

From Robbins LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

September 01, 2026

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Replimune Group Inc. and Encourages Investors to Contact the Firm

September 01, 2026

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law

September 01, 2026

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law

August 28, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

August 25, 2026

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law

August 25, 2026

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Replimune Group Inc. and Encourages Investors to Contact the Firm

August 21, 2026

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law

August 21, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

August 21, 2026

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 19, 2026

From Replimune, Inc.